Active	Status	Sponsor type	Region	Phase	Filter
15 Active 29 Inactive 44 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

15 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dummer, Reinhard
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma	Recruiting	2/3	420	Europe, Canada, US, RoW	IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome	IDEAYA Biosciences	Metastatic Uveal Melanoma	01/27	01/28
Nov IIT- Pyrex, NCT04652258: Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy	Terminated	2	20	Europe	Actemra	University of Zurich	Pyrexia	10/21	10/21
NCT05529316: A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma	Active, not recruiting	2	220	Europe, US, RoW	Botensilimab, AGEN1181, Balstilimab, AGEN2034	Agenus Inc.	Advanced Melanoma	05/28	05/28
DUNCAN, NCT04362722 / 2020-003299-42: Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients	Recruiting	2	40	Europe	L19IL2 +L19TNF, bifikafusp alfa + onfekafusp alfa	Philogen S.p.A., Philogen S.p.A.	Carcinoma, Basal Cell, Carcinoma, Cutaneous Squamous Cell	09/24	09/24
NCT04679480: Anti-PD1-antibody and Pulsed HHI for Advanced BCC	Active, not recruiting	2	20	Europe	Cemiplimab Injection [Libtayo], Sonidegib	Reinhard Dummer, Sanofi, Sun Pharmaceutical Industries Ltd	Basal Cell Carcinoma	12/24	12/24
NCT05120596: First in Human Study of T3P-Y058-739 (T3P)	Recruiting	1/2	100	Europe	Pembrolizumab+T3P-Y058-739, T3P-Y058-739 (IV), T3P-Y058-739 (IT)	T3 Pharmaceuticals AG	Advanced Solid Tumor	02/26	10/26
GDFATHER, NCT04725474 / 2020-002103-19: First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer	Active, not recruiting	1/2	274	Europe	visugromab (CTL-002)	CatalYm GmbH, CatalYm GmbH	Solid Tumor, Adult	10/25	10/27
SGNBB228-001, NCT05571839: A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors	Recruiting	1	275	Europe, Canada, US	PF-08046049	Seagen Inc.	Cutaneous Melanoma, Non-small Cell Lung Cancer, Colorectal Neoplasms, Pancreatic Neoplasms, Mesothelioma	11/26	11/27
Hofbauer, Günther
NCT01976468: Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"	Active, not recruiting	N/A	100	Europe	SCC metastasis	University of Zurich, Leiden University Medical Center	Squamous Cell Carcinoma	01/23	01/25
Hofbauer, Guenther
NCT02205593: Haut-Tief Patient Education on Psoriasis and Eczema	Active, not recruiting	N/A	80	Europe	Control	University of Zurich	Psoriasis, Atopic Dermatitis/ Eczema	10/18	12/22
Bavinck, Jan Nico Bouwes
NCT01976468: Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"	Active, not recruiting	N/A	100	Europe	SCC metastasis	University of Zurich, Leiden University Medical Center	Squamous Cell Carcinoma	01/23	01/25
Genders, Roel
NCT01976468: Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"	Active, not recruiting	N/A	100	Europe	SCC metastasis	University of Zurich, Leiden University Medical Center	Squamous Cell Carcinoma	01/23	01/25
Schmid-Grendelmeier, Peter
TRALIS, NCT05378698: Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation	Not yet recruiting	2/3	25	Europe	Application of Tralokinumab	University of Zurich, Hochgebirgsklinik Davos-Wolfgang	Atopic Dermatitis	12/24	06/25
ILIT-FNA, NCT05960266: Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study	Active, not recruiting	1	28	Europe	Polvac Grass+Rye	University of Zurich	Hypersensitivity, Hay Fever, Rhinitis, Allergic, Seasonal, Rhinoconjunctivitis	05/24	12/24
ProRaD, NCT04240522: Prospective Longitudinal Observational Research in Atopic Dermatitis	Recruiting	N/A	1000	Europe		University of Zurich, University of Bonn	Atopic Dermatitis, Asthma, Atopic Dermatitis and Related Conditions	04/24	04/24